Guardant Health
GH
#1154
Rank
C$28.13 B
Marketcap
C$207.98
Share price
1.30%
Change (1 day)
55.61%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Annual Reports

Thumbnail Guardant Health
 Annual Report 2022

Annual Report 2022

Language: English

View Annual Report